目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Treatment
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Onychomycosis Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis

Chapter 4. Onychomycosis Market: Type Business Analysis
4.1. Type Market Share, 2025 & 2033
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
4.4. Distal Subungual Onychomycosis
4.4.1. Distal Subungual Onychomycosis Market, 2021 - 2033 (USD Million)
4.5. White Superficial Onychomycosis
4.5.1. White Superficial Onychomycosis Market, 2021 - 2033 (USD Million)
4.6. Proximal Subungual Onychomycosis
4.6.1. Proximal Subungual Onychomycosis Market, 2021 - 2033 (USD Million)
4.7. Other Types
4.7.1. Other Types Market, 2021 - 2033 (USD Million)

Chapter 5. Onychomycosis Market: Treatment Business Analysis
5.1. Treatment Market Share, 2025 & 2033
5.2. Treatment Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
5.4. Oral
5.4.1. Oral Market, 2021 - 2033 (USD Million)
5.5. Topical
5.5.1. Topical Market, 2021 - 2033 (USD Million)
5.6. Others
5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Onychomycosis Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Onychomycosis Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Europe
6.5.1. Europe Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. Uk Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Onychomycosis Market Estimates and Forecasts, 2017 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Onychomycosis Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Bausch Health Companies Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. GSK plc
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Abbott
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Pfizer Inc
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Bayer AG
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Teva Pharmaceutical Industries Ltd.
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Cipla
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Merck & Co., Inc.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Novartis AG
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Sun Pharmaceutical Industries Ltd.
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global onychomycosis market, by region, 2021 - 2033 (USD Million)
Table 4 Global onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 5 Global onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 6 North America onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 7 North America onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 8 North America onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 9 U.S. onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 10 U.S. onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 11 Canada onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 12 Canada onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 13 Mexico onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 14 Mexico onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 15 Europe onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 16 Europe onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 17 Europe onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 18 UK onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 19 UK onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 20 Germany onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 21 Germany onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 22 France onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 23 France onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 24 Italy onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 25 Italy onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 26 Spain onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 27 Spain onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 28 Norway onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 29 Norway onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 30 Denmark onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 31 Denmark onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 32 Sweden onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 33 Sweden onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 34 Asia Pacific onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 35 Asia Pacific onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 36 Asia Pacific onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 37 Japan onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 38 Japan onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 39 China onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 40 China onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 41 India onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 42 India onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 43 Australia onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 44 Australia onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 45 South Korea onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 46 South Korea onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 47 Thailand onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 48 Thailand onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 49 Latin America onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 50 Latin America onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 51 Latin America onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 52 Brazil onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 53 Brazil onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 54 Argentina onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 55 Argentina onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 56 Middle East & Africa Onychomycosis market, by country, 2021 - 2033 (USD Million)
Table 57 Middle East & Africa onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 58 Middle East & Africa onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 59 South Africa onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 60 South Africa onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 61 Saudi Arabia onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 62 Saudi Arabia onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 63 UAE onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 64 UAE onychomycosis market, by treatment, 2021 - 2033 (USD Million)
Table 65 Kuwait onychomycosis market, by type, 2021 - 2033 (USD Million)
Table 66 Kuwait onychomycosis market, by treatment, 2021 - 2033 (USD Million)

List of Figures
Fig. 1 Onychomycosis market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and application outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Onychomycosis market dynamics
Fig. 12 Onychomycosis market: Porter’s five forces analysis
Fig. 13 Onychomycosis market: PESTLE analysis
Fig. 14 Product market, 2021 - 2033 (USD Million)
Fig. 15 Distal Subungual Onychomycosis market, 2021 - 2033 (USD Million)
Fig. 16 White Superficial Onychomycosis market, 2021 - 2033 (USD Million)
Fig. 17 Proximal Subungual Onychomycosis market, 2021 - 2033 (USD Million)
Fig. 18 Other Types market, 2021 - 2033 (USD Million)
Fig. 19 Treatment market, 2021 - 2033 (USD Million)
Fig. 20 Oral market, 2021 - 2033 (USD Million)
Fig. 21 Topical market, 2021 - 2033 (USD Million)
Fig. 22 Others market, 2021 - 2033 (USD Million)
Fig. 23 Onychomycosis market revenue, by region
Fig. 24 Regional marketplace: Key takeaways
Fig. 25 North America onychomycosis market, 2021 - 2033 (USD Million)
Fig. 26 U.S. country dynamics
Fig. 27 U.S. onychomycosis market, 2021 - 2033 (USD Million)
Fig. 28 Canada country dynamics
Fig. 29 Canada onychomycosis market, 2021 - 2033 (USD Million)
Fig. 30 Mexico country dynamics
Fig. 31 Mexico onychomycosis market, 2021 - 2033 (USD Million)
Fig. 32 Europe onychomycosis market, 2021 - 2033 (USD Million)
Fig. 33 UK country dynamics
Fig. 34 UK onychomycosis market, 2021 - 2033 (USD Million)
Fig. 35 Germany country dynamics
Fig. 36 Germany onychomycosis market, 2021 - 2033 (USD Million)
Fig. 37 France country dynamics
Fig. 38 France onychomycosis market, 2021 - 2033 (USD Million)
Fig. 39 Italy country dynamics
Fig. 40 Italy onychomycosis market, 2021 - 2033 (USD Million)
Fig. 41 Spain country dynamics
Fig. 42 Spain onychomycosis market, 2021 - 2033 (USD Million)
Fig. 43 Norway country dynamics
Fig. 44 Norway onychomycosis market, 2021 - 2033 (USD Million)
Fig. 45 Sweden country dynamics
Fig. 46 Sweden onychomycosis market, 2021 - 2033 (USD Million)
Fig. 47 Denmark country dynamics
Fig. 48 Denmark onychomycosis market, 2021 - 2033 (USD Million)
Fig. 49 Asia Pacific onychomycosis market, 2021 - 2033 (USD Million)
Fig. 50 Japan country dynamics
Fig. 51 Japan onychomycosis market, 2021 - 2033 (USD Million)
Fig. 52 China country dynamics
Fig. 53 China onychomycosis market, 2021 - 2033 (USD Million)
Fig. 54 India country dynamics
Fig. 55 India onychomycosis market, 2021 - 2033 (USD Million)
Fig. 56 Australia country dynamics
Fig. 57 Australia onychomycosis market, 2021 - 2033 (USD Million)
Fig. 58 South Korea country dynamics
Fig. 59 South Korea onychomycosis market, 2021 - 2033 (USD Million)
Fig. 60 Thailand country dynamics
Fig. 61 Thailand onychomycosis market, 2021 - 2033 (USD Million)
Fig. 62 Latin America onychomycosis market, 2021 - 2033 (USD Million)
Fig. 63 Brazil country dynamics
Fig. 64 Brazil onychomycosis market, 2021 - 2033 (USD Million)
Fig. 65 Argentina country dynamics
Fig. 66 Argentina onychomycosis market, 2021 - 2033 (USD Million)
Fig. 67 MEA onychomycosis market, 2021 - 2033 (USD Million)
Fig. 68 South Africa country dynamics
Fig. 69 South Africa onychomycosis market, 2021 - 2033 (USD Million)
Fig. 70 Saudi Arabia country dynamics
Fig. 71 Saudi Arabia onychomycosis market, 2021 - 2033 (USD Million)
Fig. 72 UAE country dynamics
Fig. 73 UAE onychomycosis market, 2021 - 2033 (USD Million)
Fig. 74 Kuwait country dynamics
Fig. 75 Kuwait onychomycosis market, 2021 - 2033 (USD Million)
Fig. 76 Company categorization
Fig. 77 Company market position analysis
Fig. 78 Strategic framework